Related Experiment Videos
Application of toxicogenomics to drug development
Maha M Lakkis1, Marc F DeCristofaro, Hans J Ahr
1Pharmacogenomics Department, CuraGen, Corp., 555 Long Wharf Drive, 13th Floor, New Haven, CT 06511, USA. mlakkis@curagen.com
Expert Review of Molecular Diagnostics
|July 26, 2002
Summary
Toxicogenomics offers a revolutionary approach to drug toxicity assessment, aiming to reduce late-stage failures and development costs. This new discipline promises early screening of drug candidates, enhancing pharmaceutical safety evaluations.
Area of Science:
- Biomedical Research
- Chemical Research
- Pharmaceutical Industry
Background:
- Advanced technologies increase drug targets but high toxicity failure rates persist.
- Late-stage developmental failures in drug discovery are costly and time-consuming.
- The pharmaceutical industry seeks innovative solutions for efficient drug safety assessment.
Purpose of the Study:
- To provide a general description of toxicogenomics.
- To explore the potential impact of toxicogenomics on drug safety assessment.
- To outline current challenges and future prospects in toxicogenomics.
Main Methods:
- Review of toxicogenomics principles and applications.
- Analysis of the role of toxicogenomics in pharmaceutical development.
- Discussion of key issues and future directions in the field.
Main Results:
- Toxicogenomics can significantly enhance drug toxicity assessment.
- Early screening of compounds can reduce development bottlenecks and costs.
- The discipline holds promise for minimizing late-stage drug development failures.
Conclusions:
- Toxicogenomics is poised to revolutionize drug toxicity assessment.
- Early identification of toxic compounds can lead to significant time and cost savings.
- Addressing current challenges will be crucial for realizing the full potential of toxicogenomics.